Development of a Nanogold-Based Lateral Flow Immunoassay for Point-of-Care Detection of SARS-CoV-2 Nucleocapsid Proteins and Antibodies
The ongoing COVID-19 pandemic has underscored the urgent need for rapid, sensitive, and versatile diagnostic tools. In this study, we developed a nanogold-based lateral flow immunoassay (LFIA) capable of detecting both SARS-CoV-2 nucleocapsid (N) protein antigens and anti-N IgG antibodies at the poi...
Furkejuvvon:
| Váldodahkkit: | , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
MDPI AG
2025-09-01
|
| Ráidu: | COVID |
| Fáttát: | |
| Liŋkkat: | https://www.mdpi.com/2673-8112/5/9/158 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|